Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: A potential therapeutic application in multiple myeloma and other plasma cell disorders
Clinical Cancer Research, 07/06/2012
Bae J et al. – The results highlight the potential therapeutic application of vaccination with a cocktail of HLA–A2 specific peptides to induce cytotoxic T lymphocytes (CTL) with a broad spectrum of immune responses against multiple myeloma antigens.



